|
SEC23A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.954600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.424500E-02 |
| Normal-vs-Stage2 |
5.463800E-01 |
| Normal-vs-Stage3 |
8.001800E-02 |
| Normal-vs-Stage4 |
9.288400E-01 |
| Stage1-vs-Stage2 |
4.460800E-01 |
| Stage1-vs-Stage3 |
7.500800E-03 |
| Stage1-vs-Stage4 |
3.433400E-01 |
| Stage2-vs-Stage3 |
4.786000E-02 |
| Stage2-vs-Stage4 |
7.341600E-01 |
| Stage3-vs-Stage4 |
1.329180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.454200E-01 |
| Normal-vs-AfricanAmerican |
9.230100E-02 |
| Normal-vs-Asian |
6.768800E-01 |
| Caucasian-vs-AfricanAmerican |
1.807230E-01 |
| Caucasian-vs-Asian |
5.802400E-01 |
| AfricanAmerican-vs-Asian |
4.408800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.217240E-01 |
| Normal-vs-Female |
2.633200E-01 |
| Male-vs-Female |
7.084500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.844000E-01 |
| Normal-vs-Extreme_Weight |
1.184250E-02 |
| Normal-vs-Obese |
7.328400E-01 |
| Normal-vs-Extreme_Obese |
2.971600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.908170E-01 |
| Normal_Weight-vs-Obese |
4.466000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.503000E-01 |
| Extreme_Weight-vs-Obese |
1.960180E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.201600E-01 |
| Obese-vs-Extreme_Obese |
3.997600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.061600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.886000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.721900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.060400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.000800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.458200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.382160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.497700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.162600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.233800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.689810E-02 |
| Normal-VS-Type2 PRCC |
4.166200E-01 |
| Normal-VS-KIRP CIMP |
1.129580E-01 |
| Normal-VS-Unclassified PRCC |
7.970800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.895300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.824000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.740800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.658650E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.178800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.302570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.776600E-01 |
| Normal-vs-N1 |
8.253600E-02 |
| Normal-vs-N2 |
6.434400E-01 |
| N0-vs-N1 |
6.877500E-02 |
| N0-vs-N2 |
6.885200E-01 |
| N1-vs-N2 |
5.853000E-01 |
|
|
